Alan Prem Kumar
Senior Research Scientist, Department of Pharmacology
Cancer Science Institute of Singapore, Singapore
He is a Post-Doctoral Fellow in Sidney Kimmel Cancer Center at San Diego, California, USA, and works as a Research Fellow in Dept. of Physiology, NUS. He worked as a Research Scientist in National University Medical Institutes (NUMI), NUS.
Presently he is in Scientific Advisory Board in Bioexplore in India and Visiting Research Fellow at The University of Western Australia, Crawley, WA.
Diabetes and cancer are common diseases among adults worldwide. New research shows that both hyperinsulinaemia and hyperglycemia, characteristics of type 2 diabetes, are major risk factors for a number of cancer-promotes tumor development. My area of research focuses on exploring the role of nuclear receptors, such as PPARs (peroxisome proliferator-activated receptors), ERα, HNF4α, and DEAD-box RNA helicases in the prevention and treatment of cancer and diabetes.